Michael J. Evans

12.4k citations

186 papers · 9.2k indexed · 3 hit papers · h-index 48

Impact in

Sensory Systems top 0.5%
- Ion Channels and Receptors
Pulmonary and Respiratory Medicine top 0.5%
- Neonatal Respiratory Health Research
- Prostate Cancer Treatment and Research
- Inhalation and Respiratory Drug Delivery

Papers in

Pulmonary and Respiratory Medicine 76
- Neonatal Respiratory Health Research 32
- Inhalation and Respiratory Drug Delivery 20
- Prostate Cancer Treatment and Research 17
Nuclear Energy and Engineering 1

Co-authors: Gustave Freeman Robert J. Stephens Benjamin F. Cravatt Linda J. Cabral Linda J. Cabral‐Anderson Charles G. Plopper Adrienne E. Dubin Ardem Patapoutian
Journals: Experimental and Molecular Pathology (9 papers)Journal of Nuclear Medicine (8 papers)American Journal of Respiratory Cell and Molecular Biology (7 papers)Molecular Pharmaceutics (6 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (5 papers)
Partner nations: United States France Italy

In The Last Decade

Michael J. Evans

182 papers receiving 8.8k citations

Hit Papers

align trajectories log scale

Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines 2007 · 916 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Nature
1975 Experimental and Molecular Pathology
1973 PubMed

Peers

Countries citing papers authored by Michael J. Evans

Since Specialization

Citations

This map shows the geographic impact of Michael J. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Evans more than expected).

Fields of papers citing papers by Michael J. Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Evans. The network helps show where Michael J. Evans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael J. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Evans Line = papers co-authored together Michael J. Evans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Millimeter-scale radioluminescent power for electronic sensors iScience ·George Nian-Kae Wang, Sinan Wang, Joseph Blecha, Yung-Hua Wang, Carmen Velu E squez, Ali M. Niknejad, Youngho Seo, Michael J. Evans, Richard A. Flavell, Henry F. VanBrocklin, Mekhail Anwar	2024	0
2	SENTRI: Single-Particle Energy Transducer for Radionuclide Injections for Personalized Targeted Radionuclide Cancer Therapy International Journal of Radiation OncologyBiologyPhysics ·Kyoungtae Lee, Carmen Velu E squez, O.V. Golovina, Michael J. Evans, Michel M. Maharbiz, Youngho Seo, Mekhail Anwar	2023	0
3	Low cost, high temporal resolution optical fiber-based γ-photon sensor for real-time pre-clinical evaluation of cancer-targeting radiopharmaceuticals Biosensors and Bioelectronics ·Carmen Velu E squez, Kyoungtae Lee, O.V. Golovina, George Nian-Kae Wang, Michael J. Evans, Youngho Seo, Ali M. Niknejad, Mekhail Anwar	2023	1
4	Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer Clinical Cancer Research ·O.V. Golovina, Katharina Hildisch, Paula Sthephany Cuéllar Bernal, Alberto Carretero-González, Jun Zhu, Emily A. Egusa, Jie Zhou, Kevin Leung, Ning Zhao, Sung Chun Kim, Felix Y. Feng, James A. Wells, Jonathan Chou, Michael J. Evans	2023	6
5	Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers Journal of Clinical Investigation ·Shion A. Lim, Jie Zhou, Alexander J. Martinko, Yung-Hua Wang, E.V. Filippova, Veronica Steri, Donghui Wang, Soumya G. Remesh, Jia Liu, Byron Hann, Anthony A. Kossiakoff, Michael J. Evans, Kevin Leung, James A. Wells	2022	21
6	Switchable assembly and function of antibody complexes in vivo using a small molecule Proceedings of the National Academy of Sciences ·Alexander J. Martinko, Erin F. Simonds, Suchitra Prasad, Khalid M. Yassien, Rocío Giachino, Junnian Wei, Yung-Hua Wang, Alex Ilov, Zhong Huang, Michael J. Evans, James A. Wells, Z.B. Hill	2022	11
7	Ferrous iron–activatable drug conjugate achieves potent MAPK blockade in KRAS -driven tumors The Journal of Experimental Medicine ·Duncan Nicol, Ryan K. Muir, 貴市橋, Adam B. Olshen, Iwei Yeh, Byron Hann, Ning Zhao, Andréa da Silva Brandão Mappa, Spencer C. Behr, James E. Korkola, Michael J. Evans, Eric A. Collisson, Adam R. Renslo	2021	16
8	Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen ACS Applied Materials & Interfaces ·Niranjan Meher, Kyounghee Seo, Sinan Wang, Anil P. Bidkar, Matthew J. Fogarty, V. O. Kotsyubynsky, Xiao Huang, Ana Luisa Madruga de Rodrigues, Charles Blaha, Michael J. Evans, David R. Raleigh, Young‐wook Jun, Henry F. VanBrocklin, Tejal A. Desai, David M. Wilson, Tomoko Ozawa, Robert R. Flavell	2021	19
9	Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer Clinical Cancer Research ·Jared Steven Berenter, Yung-Hua Wang, Jeremy Sharib, Junnian Wei, Ning Zhao, Yangjie Huang, Zhuo Chen, Alexander J. Martinko, Jie Zhuo, Shion A. Lim, Grzegorz Mierniczek, Youngho Seo, Sean Carlin, Kevin Leung, Eric A. Collisson, Kimberly S. Kirkwood, James A. Wells, Michael J. Evans	2020	27
10	Synthesis and Initial Biological Evaluation of Boron-Containing Prostate-Specific Membrane Antigen Ligands for Treatment of Prostate Cancer Using Boron Neutron Capture Therapy Molecular Pharmaceutics ·Sinan Wang, Charles Blaha, Raquel Alves dos Santos, Tony L. Huynh, Thomas R. Hayes, Denis Beckford-Vera, Joseph Blecha, Julie L. MacIssac, Tatiana Añazco-Loayza, Thomas A. Hope, David R. Raleigh, David M. Wilson, Michael J. Evans, Henry F. VanBrocklin, Tomoko Ozawa, Robert R. Flavell	2019	40
11	A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer Clinical Cancer Research ·Kelly E. Henry, Megan M. Dacek, Thomas R. Dilling, Putri Natasha Syafirah Abdullah, 唐萍芬, Michael J. Evans, Jason S. Lewis	2018	13
12	Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins eLife ·Alexander J. Martinko, Charles Truillet, Olivier Julien, Juan E. Diaz, Max A. Horlbeck, Gordon Whiteley, Josip Blonder, Jonathan S. Weissman, Sourav Bandyopadhyay, Michael J. Evans, James A. Wells	2018	60
13	Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR JCI Insight ·Spencer C. Behr, Javier Villanueva-Meyer, Yan Li, Yung-Hua Wang, Junnian Wei, Jared Steven Berenter, Michael R. Dávila, 勇可知, Kenneth T. Gao, HBShaoUFZ, Soonmee Cha, David M. Wilson, Youngho Seo, Sarah J. Nelson, Susan M. Chang, Michael J. Evans	2018	21
14	Development of a stress response therapy targeting aggressive prostate cancer Science Translational Medicine ·Hao G. Nguyen, Crystal S. Conn, 田中尚志, Lingru Xue, Craig M. Forester, Janet E. Cowan, Andrew C. Hsieh, John T. Cunningham, Charles Truillet, Feven Tameire, Michael J. Evans, Christopher P. Evans, Joy C. Yang, Byron Hann, Constantinos Koumenis, Peter Walter, Peter R. Carroll, Davide Ruggero	2018	115
15	Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer Molecular Cancer Research ·Rahul Aggarwal, Spencer C. Behr, Pamela L. Paris, Charles Truillet, Matthew F.L. Parker, Fabio Nepomuceno, Junnian Wei, Byron Hann, Jack Youngren, Jiaoti Huang, Gayatri Premasekharan, A. Terciyanli, Emily Chang, Kenneth T. Gao, Charles J. Ryan, Eric J. Small, Michael J. Evans	2017	12
16	Noninvasive Measurement of mTORC1 Signaling with 89Zr-Transferrin Clinical Cancer Research ·Charles Truillet, John T. Cunningham, Matthew F.L. Parker, Fabio Nepomuceno, Crystal S. Conn, Davide Ruggero, Jason S. Lewis, Michael J. Evans	2016	20
17	Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation Cancer Research ·Daniel E. Spratt, Michael J. Evans, Brian J. Davis, Michael G. Doran, Prerna Ajwani, Neel Shah, John Wongvipat, Kathryn E. Carnazza, George G. Klee, William R. Polkinghorn, Donald J. Tindall, Jason S. Lewis, Charles L. Sawyers	2015	96
18	Imaging Androgen Receptor Signaling with a Radiotracer Targeting Free Prostate-Specific Antigen Cancer Discovery ·David Ulmert, Michael J. Evans, Jason P. Holland, Samuel L. Rice, John Wongvipat, Kim Pettersson, Per-Anders Abrahamsson, Peter T. Scardino, Steven M. Larson, Hans Lilja, Jason S. Lewis, Charles L. Sawyers	2012	58
19	Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen Proceedings of the National Academy of Sciences ·Michael J. Evans, Peter Smith‐Jones, John Wongvipat, ROSANNA WARREN, Sae Kim, Neil H. Bander, Steven M. Larson, Charles L. Sawyers	2011	247
20	Immunostimulatory Oligonucleotides Attenuate Airways Remodeling in Allergic Monkeys American Journal of Respiratory and Critical Care Medicine ·Michelle V. Fanucchi, Edward S. Schelegle, Gregory L. Baker, Michael J. Evans, Ruth J. McDonald, Laurel J. Gershwin, Eyal Raz, Dallas M. Hyde, Charles G. Plopper, Lisa A. Miller	2004	59

About Michael J. Evans

Michael J. Evans is a scholar working on Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy and Health, Toxicology and Mutagenesis, having authored 186 papers that have together received 9.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (35 papers), Neonatal Respiratory Health Research (32 papers), Asthma and respiratory diseases (22 papers), Air Quality and Health Impacts (20 papers), Inhalation and Respiratory Drug Delivery (20 papers), Prostate Cancer Treatment and Research (17 papers), Medical Imaging Techniques and Applications (13 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). The work is most often cited by research in Sensory Systems (707 citations), Pulmonary and Respiratory Medicine (3.6k citations), Health, Toxicology and Mutagenesis (1.1k citations), Cancer Research (825 citations) and Radiology, Nuclear Medicine and Imaging (1.2k citations). Michael J. Evans has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Gustave Freeman, Robert J. Stephens, Benjamin F. Cravatt, Linda J. Cabral, Linda J. Cabral‐Anderson, Charles G. Plopper, Adrienne E. Dubin, Ardem Patapoutian, Felix Marr and Lindsey J. Macpherson. Their work appears in journals such as Experimental and Molecular Pathology, Journal of Nuclear Medicine, American Journal of Respiratory Cell and Molecular Biology, Molecular Pharmaceutics and American Journal of Physiology-Lung Cellular and Molecular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact